WHO strongly recommends antiviral

antiviral

WHO strongly recommends antiviral drug for patients with non-severe covid-19: A combination of nirmatrelvir and ritonavir is strongly recommended for patients at highest risk of hospital admission. WHO also makes a conditional recommendation for remdesivir in the same group of patients. Pfizer’s oral antiviral drug (a combination of nirmatrelvir and ritonavir tablets) is strongly recommended […]

Read More… from WHO strongly recommends antiviral

WHO: Covid-19 antiviral drug molnupiravir recommendation

molnupiravir

WHO recommends antiviral drug for patients with non-severe covid-19 at highest risk of hospital admission: The antiviral drug molnupiravir is conditionally recommended for patients with non-severe covid-19 who are at highest risk of hospitalisation, says a WHO Guideline Development Group of international experts in The BMJ today. Patients who are at highest risk of hospitalisation typically […]

Read More… from WHO: Covid-19 antiviral drug molnupiravir recommendation

Monash University: Drug repurposing is no panacea in race to treat COVID-19

repurposing drugs

Drug repurposing is no quick fix for developing new treatments for disease, including COVID-19, and  there are inherent dangers and pitfalls with translating drugs such as chloroquine, hydroxychloroquine, ivermectin and similar compounds to treat COVID-19, say a team of experts. The potential challenges and opportunities with drug repurposing are highlighted in a paper authored  by a cross-section […]

Read More… from Monash University: Drug repurposing is no panacea in race to treat COVID-19

WHO: Solidarity Therapeutics Trial

Solidarity Therapeutics Trial

Solidarity Therapeutics Trial produces conclusive evidence on the effectiveness of repurposed drugs for COVID-19 in record time In just six months, the world’s largest randomized control trial on COVID-19 therapeutics has generated conclusive evidence on the effectiveness of repurposed drugs for the treatment of COVID-19. Interim results from the Solidarity Therapeutics Trial, coordinated by the […]

Read More… from WHO: Solidarity Therapeutics Trial

Remdesivir treatment for coronavirus in cats

cats and coronavirus

Remdesivir may not be the ‘magic bullet’ for patients with COVID-19, but it may greatly benefit cats suffering from a deadly disease caused by a different coronavirus. As well as infecting humans, coronaviruses can cause a wide range of diseases in other species including dogs, cats, pigs, cows, mice, bats, birds and ferrets. Despite the […]

Read More… from Remdesivir treatment for coronavirus in cats